MTEC Commercialization Grants -2023
Medical Technology Enterprise Consortium (MTEC)
REQUEST ISSUE DATE
May 05, 2023
ENHANCED WHITEPAPER DUE
June 19, 2023
AMENDMENTS
3 Amendments
Purpose
This solicitation, issued by MTEC, represents a Request for Project Proposals (RPP) for the 2023 “MTEC Commercialization Grant” mechanism targeting the following:
- Objective: To provide non-dilutive MTEC awards that fund M-Corps partner engagement for the purpose of providing members professional services that advance commercialization readiness.
- Funding Available: $500,000 total, up to $50,000 per award
- Award Type: Grant
- Scope of Work: Business, technical, and strategic planning projects.
Scope of Work
Current wartime operations assume that the United States and our allies will maintain air, land, maritime, space, and cyber superiority. Future conflicts against peer and near-peer adversaries are expected to be layered stand-offs and fought across multiple domains. Mission success will be determined by our ability to compete to expand the competitive space, penetrate both strategically and operationally, disintegrate enemy’s defenses, exploit enemy weaknesses, and recompete to consolidate gains. Medical capabilities play a critical role in each aspect of the future battlespace and must modernize rapidly to maintain Force readiness and increase soldier lethality.
Therefore, proposed projects shall focus on providing medical solutions to support readiness and care in future battlefield scenarios in support of the areas listed on MTEC's website.
It is encouraged that potential Offerors reach out to the MTEC Director of Commercialization listed in Section 6 of this RPP to determine whether your proposed technology has military relevance, aligns with the mission of MTEC, and is within scope for this RPP.
The proposed scope of work will focus on business, technical, and strategic planning projects. Scientific and product development proposals are out of scope. Defining the value proposition for your technology, fit with military and civilian markets, as well proper strategies for IP, clinical and regulatory, market entry and reimbursement, and exits are critical to success. These grants are meant to help our small business members create and update a clear, concise strategy for their technology. Examples of the work that could be included in the scope of work are (but not limited to):
- Competitive landscape analysis / market research.
- IP protection and valuation.
- Regulatory and reimbursement strategy.
- Partnering / business development strategy.
- Engineering design and evaluation.
- Clinical trial protocol development.
Points of Contact
For inquiries, please direct your correspondence to Biomedical Research Associate Chuck Hutti, Ph.D. at Chuck.Hutti@ati.org.
Other Opportunities
Ongoing
DHA Research & Engineering Directorate
Funding Opportunity: 25-07-Pharmacogenomics "Pharmacogenomics (PGx) Testing for Military Readiness Pilot"Request for Proposal Due: June 20, 2025
NMRC and OSG of the Navy
Pre-Announcement: "Sailor Post-Traumatic Stress Disorder (PTSD) Risk Prediction Model"Ongoing
DHA/PMS 408
Funding Opportunity: 25-06-ExMedModernize "Modernization of Expeditionary Medicine (EXMED) Warfighter Prototypes"Request for Proposal Due: June 13, 2025